#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Sarcoidosis Ichthyosis Autoimmune myositis Methylmalonic acidaemia Microscopic polyangiitis Neurodermatitis T-cell lymphoma Thermal burn Mantle cell lymphoma stage IV Marginal zone lymphoma recurrent Alagille syndrome Leukoencephalopathy Insulinoma Leiomyosarcoma recurrent Fallopian tube cancer More trials…

    Learn about Rare Diseases

    Testicular leiomyosarcoma – Trials in Disease Cystic fibrosis lung – Trials in Disease Leukoencephalopathy – Life with Disease Fragile X syndrome – Basic Information Mucous membrane pemphigoid Medulloblastoma – Life with Disease Cystic fibrosis lung – Treatment Myelodysplastic syndrome Metachromatic leukodystrophy – Life with Disease Andersen-Tawil syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Propranolol SELTOREXANT Tislelizumab Ganciclovir Sodium Roxadustat Potato Starch Latanoprost Macitentan Ucart20X22 Vemircopan Ceftriaxone Tiemonium Methylsulphate Lebrikizumab Sarilumab Valproate Semisodium Ammonium Chloride Bp Nirmatrelvir Pazopanib Copanlisib Dihydrochloride Human Coagulation Factor Viii More therapies…

    Learn about Your Condition

    Spinal cord injury Post-traumatic stress disorder Arteriovenous malformation Burning mouth syndrome Chorioretinitis Hypereosinophilic syndrome Metastases to lymph nodes Uterine cancer Agitation postoperative Glomerulonephritis acute Mucous membrane pemphigoid Hyperadrenocorticism Ebola disease Colonoscopy Primary amyloidosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Venetoclax and Obinutuzumab for Adults with Recurring Chronic Lymphocytic Leukemia

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Venetoclax
    • Obinutuzumab
    Austria Bulgaria Germany Italy Romania Spain

  • Study of Venetoclax, Ibrutinib, and Rituximab or Bendamustine Combination for Patients with Untreated Mantle Cell Lymphoma Not Suitable for High-Dose Therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma
    Investigated Drugs:
    • Bendamustine
    • Ibrutinib
    • Venetoclax
    Germany Italy

  • Study on the Safety and Tolerability of ODM-212 for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1
    Investigated Drugs:
    • Odm-212
    Finland France Spain

  • Study on Omega-3 Fatty Acids for Reducing Organ Failure and Mortality in Patients with Severe Acute Pancreatitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatitis acute
    Investigated Drugs:
    • Glycerol
    • Highly Refined Fish Oil
    • Purified Egg Phospholipids
    Denmark The Netherlands

  • Study on Gene Therapy GNT0003 for Patients with Severe Crigler-Najjar Syndrome Requiring Phototherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Crigler-Najjar syndrome
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 2/8 Containing The Human Ugt1A1 Gene
    • Bromhexine Hydrochloride
    • Sulfamethoxazole
    France Italy The Netherlands

  • Study on Palonosetron and Netupitant for Preventing Nausea in Endometrial Cancer Patients Undergoing Taxane-Platinum Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prophylaxis of nausea and vomiting
    Investigated Drugs:
    • Netupitant
    • Dexamethasone Phosphate
    • Palonosetron
    Italy
Previous Page
1 … 547 548 549 550 551 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!